Loading…
Johnson Pharmacare (BSE 532154)₹0.46000.00%Diversified Commercial Services
Johnson Pharmacare is compared with the 10 closest in size in Diversified Commercial Services (149 companies in the industry). It has a ROCE of −104.9% against a peer median of 2.1%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Diversified Commercial Services
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Falcon Technoprojects India | 30 | 9.8 | 11.2 | 12.4 | 1.34 | 0.0 | 57 | 3 | 213.6 | 636.1 | vs BSE 532154 |
| Parle Industries | 27 | — | 0.1 | −0.1 | 0.03 | 0.0 | 1 | −0 | 2,336.0 | −7,066.7 | vs BSE 532154 |
| Shreevatsaa Finance & Leasing | 27 | 60.0 | 2.1 | 1.5 | 0.00 | 0.0 | 1 | 0 | −4.3 | −37.5 | vs BSE 532154 |
| Disha Resources | 26 | — | −0.1 | −0.1 | 0.00 | 0.0 | 1 | −0 | 1,750.0 | — | vs BSE 532154 |
| Samyak International | 26 | — | 1.5 | −0.7 | 0.03 | 0.0 | 42 | 0 | 34.7 | — | vs BSE 532154 |
| Johnson Pharmacare | 25 | — | −104.9 | −146.0 | 48.55 | 0.0 | 0 | −56 | — | — | — |
| Gemstone Investments | 25 | 58.8 | 1.9 | 1.1 | 0.07 | 0.0 | 2 | 0 | 167.6 | 263.6 | vs BSE 532154 |
| Esaar (India) | 23 | 2.1 | 31.0 | 35.5 | 1.18 | 0.0 | 41 | 11 | 602.0 | — | vs BSE 532154 |
| Frontier Capital | 22 | 222.5 | 5.4 | 1.8 | 0.07 | 0.0 | 1 | 0 | 60.0 | −190.9 | vs BSE 532154 |
| Triliance Polymers | 22 | 81.5 | 6.4 | 4.6 | 0.17 | 0.0 | 0 | 0 | — | −80.0 | vs BSE 532154 |
| Greencrest Financial Services | 21 | 9.5 | 5.1 | 2.4 | 0.90 | 0.0 | 38 | 1 | 15.3 | — | vs BSE 532154 |
| Peer median | 25 | 58.8 | 2.1 | 1.5 | 0.07 | 0.0 | 1 | 0 | 167.6 | −58.8 |
Listed companies closest to Johnson Pharmacare in Diversified Commercial Services include Falcon Technoprojects India, Parle Industries, Shreevatsaa Finance & Leasing, Disha Resources, Samyak International, Gemstone Investments, Esaar (India), Frontier Capital.
Falcon Technoprojects India, with a market cap of ₹30.02 Cr.
Johnson Pharmacare's return on capital employed is −104.9%, below the peer median of 2.1%.